NEW DELHI: India has given the green light to the Covid-19 vaccine developed by the University of Oxford-AstraZeneca and three other candidate vaccines are awaiting authorization for emergency use (USA), Union Minister Prakash Javadekar confirmed on Saturday . Sources had told TOI on Friday that the Indian drug regulator’s committee …
Read More »
Union states and territories across the country are conducting a trial of the coronavirus vaccination process today. It is being carried out in 116 districts at 259 sites, the Health Ministry said on Saturday. The test will be carried out in an integral way of the COVID-19 vaccination process and …
Read More »
A committee of experts from the country’s top drug regulator recommended on Friday that Covishield, the Indian version of the Covid-19 vaccine developed by the University of Oxford and AstraZeneca, should be approved under certain conditions, The Indian Express has learned. The recommendation is hugely significant as it paves the …
Read More »
India will hold a trial on Saturday before the actual vaccination campaign against the coronavirus disease (Covid-19) in an end-to-end exercise in which all steps will be tested in the states and territories of the Union. The activity will take place in all state capitals at at least three session …
Read More »
A lakh twenty-five thousand frontline healthcare workers have been included to receive the Covid-19 vaccine under emergency use, as preparations for the distribution, storage and administration of the vaccine in Mumbai entered the final stage this week. On Tuesday, more than one hundred BMC officials, including all executive health officials, …
Read More »
A government panel of experts reportedly approved the vaccine, developed by AstraZeneca and the University of Oxford, for emergency use in India to provide immunity against coronavirus disease (Covid-19). According to the Reuters news agency, a committee of experts in the field, created by the Comptroller General of Drugs of …
Read More »
A committee of subject matter experts established by the Comptroller General of Drugs of India (DCGI) to review COVID-19 vaccine proposals, recommended an “interim efficacy analysis for Covaxin.” The vaccine was developed by Bharat Biotech in collaboration with the Indian Council for Medical Research (ICMR). The expert committee asked a …
Read More »
NEW DELHI: The drug regulator’s Subject Matter Experts Committee (SEC) recommended on Friday the granting of an Emergency Use Authorization (USA) for the Serum Institute of India’s ‘Covishield’, raising hopes that it will soon be Covid vaccine available in India. The sources said that the SEC has recommended the EUA …
Read More »
Coronavirus: Oxford COVID-19 vaccine being manufactured by the Serum Institute of India will go to DCGI New Delhi: The Oxford COVID-19 vaccine manufactured by the Serum Institute of India will be submitted for approval to the regulator Drugs Controller General of India (DCGI) by a government-appointed panel of experts, the …
Read More »
India’s drug regulator will approve a coronavirus vaccine developed by AstraZeneca and Oxford University for emergency use on Friday, three sources with knowledge of the matter said. The decision would pave the way for the launch of the vaccine in the second most populous country in the world, which, after …
Read More »